Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04584255
Title Niraparib + Dostarlimab In BRCA Mutated Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale University Cancer Center RECRUITING New Haven Connecticut 06520 United States Details
Johns Hopkins University RECRUITING Baltimore Maryland 21287 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
Beth Israel Deaconess Medical Center RECRUITING Boston Massachusetts 02215 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Mayo Clinic RECRUITING Rochester Minnesota 55905 United States Details
Vanderbilt-Ingram Cancer Center RECRUITING Nashville Tennessee 37232 United States Details
Harris Health System - Smith Clinic WITHDRAWN Houston Texas 77054 United States Details
University of Washington / Fred Hutchinson Cancer Center RECRUITING Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field